Related Experiment Video
Updated: Jul 27, 2025

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
JAK Signaling Is Critically Important in Cytokine-Induced Viral Susceptibility of Keratinocytes
Kimberly A Arnold1, Liam F Peterson2, Lisa A Beck1,2
1Departments of Dermatology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Abstract:
Little is known about whether type 1 (IFNγ), 2 (IL-4/IL-13), or 3 (IL-17A/IL-22) cytokines affect the susceptibility of keratinocytes (KC) to viruses. These immune pathways predominate in various skin diseases: lupus, atopic dermatitis (AD), and psoriasis, respectively. Janus kinase inhibitors (JAKi) are approved to treat both AD and psoriasis, and are in clinical development for lupus. We evaluated whether these cytokines alter viral susceptibility of KC and determined if this effect is modulated by treatment with JAKi. Viral susceptibility to vaccinia virus (VV) or herpes simplex virus-1 (HSV-1) ± JAKi was assessed in immortalized and primary human KC pretreated with cytokines. Exposure to type 2 (IL-4 + IL-13) or the type 3 (IL-22) cytokines significantly increased KC viral susceptibility. Specifically, there was a peak increase of 12.2 ± 3.1-fold (IL-4 + IL-13) or 7.7 ± 2.8-fold (IL-22) in VV infection as measured by plaque number. Conversely, IFNγ significantly reduced susceptibility to VV (63.1 ± 64.4-fold). The IL-4 + IL-13-induced viral susceptibility was reduced (44 ± 16%) by JAK1 inhibition, while the IL-22-enhanced viral susceptibility was diminished (76 ± 19%) by TYK2 inhibition. IFNγ-mediated resistance to viral infection was reversed by JAK2 inhibition (366 ± 294% increase in infection). Cytokines expressed in AD skin (IL-4, IL-13, IL-22) increase KC viral susceptibility while IFNγ is protective. JAKi that target JAK1 or TYK2 reversed cytokine-enhanced viral susceptibility, while JAK2 inhibition reduced the protective effects of IFNγ.
Insights
Certain immune signaling proteins, like IL-4/IL-13 and IL-22, increase skin cell susceptibility to viruses, while IFNγ offers protection. Janus kinase inhibitors (JAKi) can modulate these effects.
Area of Science:
- Immunology
- Dermatology
- Virology
Background:
- Keratinocytes (KC) are crucial for skin immunity and barrier function.
- Type 1 (interferon-gamma, IFNγ), type 2 (interleukin-4/13, IL-4/IL-13), and type 3 (IL-17A/IL-22) cytokines are implicated in skin diseases like atopic dermatitis, psoriasis, and lupus.
- Janus kinase inhibitors (JAKi) are therapeutic agents for these conditions.
Purpose of the Study:
- To investigate how type 1, 2, and 3 cytokines affect keratinocyte susceptibility to viral infections.
- To determine if JAK inhibitors can modulate cytokine-induced changes in viral susceptibility in keratinocytes.
Main Methods:
- Immortalized and primary human keratinocytes were pretreated with specific cytokines (IFNγ, IL-4/IL-13, IL-22).
- Cells were subsequently infected with vaccinia virus (VV) or herpes simplex virus-1 (HSV-1).
- The effect of JAK inhibitors (targeting JAK1, TYK2, or JAK2) on viral infection was assessed.
Main Results:
- Type 2 (IL-4 + IL-13) and type 3 (IL-22) cytokines significantly increased keratinocyte susceptibility to VV infection.
- IFNγ significantly reduced keratinocyte susceptibility to VV infection.
- JAK1 inhibition reversed IL-4/IL-13-induced susceptibility, TYK2 inhibition reversed IL-22-induced susceptibility, and JAK2 inhibition reversed IFNγ-mediated protection.
Conclusions:
- Cytokines prevalent in atopic dermatitis skin (IL-4, IL-13, IL-22) enhance keratinocyte viral susceptibility.
- IFNγ exhibits a protective effect against viral infection in keratinocytes.
- JAK inhibitors demonstrate potential in modulating these cytokine-driven changes in viral susceptibility, offering therapeutic insights for skin diseases.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
MAPK Signaling Cascades
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Extrinsic Apoptotic Pathway

